John G.F. Cleland

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2018 ESC/ESH Guidelines for the management of arterial hypertension

The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure

2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial